AI, Quantum-computer designed GlybatomaqTM small molecules, 978-613-8-91672-7, 6138916727 ,9786138916727 by ioannis Grigoriadis
GlybatomaqTM312317b: Novel Series of Quantum Thinking Ligands targeted to the Glioma target, 978-613-8-91609-3, 6138916093 ,9786138916093 by ioannis Grigoriadis
Ioannis Grigoriadis | Scientific Director | Medicinal Chemistry 2018 | Meetings International
Title: Development of a novel class of hyper-multi
FybrosenaqTM:Anti-CF QMMMIDD small molecules, 978-620-2-31492-3, 6202314923 ,9786202314923 by ioannis Grigoriadis
PDF) Quantum Deep Learning Functional Similarities on Remdesivir, Drug Synergies to Treat COVID-19 in Practice.
Organizing Committee Members | Meetings International
Ioannis Grigoriadis - QUANTUM CHEMIST DRUG DESIGNER CELL AND GENE THERAPY ENGINEER - BIOGENEA PHARMACEUTICALS LTD | LinkedIn
PDF) A Novel Combined Methodology for Isolation and Detection of Circulating Tumor Cells based on Flow Cytometry and Cellular Filtration Technologies
Chemistry Congress 2019 | Chemistry Conferences | Rome | Italy
Speakers | Drug Discovery Webinar 2021 | Drug Design Webinars | Drug Discovery Webinars | Scholars Webinars
Have a glance at our organizing committee member and Honorable Speaker – Global Medicinal Chemistry & GPCR Summit
BIOGENEA PHARMACEUTICALS LTD - ΘΕΣΣΑΛΟΝΙΚΗ - ΒΛΑΣΤΟΚΥΤΤ - 4ty.gr
2017 « H.bioinfo
Ioannis Grigoriadis - QUANTUM CHEMIST DRUG DESIGNER CELL AND GENE THERAPY ENGINEER - BIOGENEA PHARMACEUTICALS LTD | LinkedIn
Ioannis Grigoriadis (biogenea) - Προφίλ | Pinterest
GlybatomaqTM312317b: Novel Series of Quantum Thinking Ligands targeted to the Glioma target | Dodax.com
Organizing Committee | Nanotechnology Congress 2019 | Nanotechnology Meetings | World Nanotechnology Congress | Nanotechnology Conferences 2019 | Nanotechnology Conference 2019 | Nanotechnology Conferences Dubai 2019 | World Nanotechnology Conferences ...
Title: Development of a novel class of hyper-multi
Speakers | Drug Discovery Webinar 2021 | Drug Design Webinars | Drug Discovery Webinars | Scholars Webinars
The histone methyltransferase inhibitor A-366 enhances hemoglobin expression in erythroleukemia cells upon co‐exposure with chemical inducers in culture | Journal of Biological Research-Thessaloniki | Full Text
Organizing Committee Members | Meetings International
Ioannis Grigoriadis - QUANTUM CHEMIST DRUG DESIGNER CELL AND GENE THERAPY ENGINEER - BIOGENEA PHARMACEUTICALS LTD | LinkedIn
PDF) Chern-Simons Topology Geometrics for the generation of the RoccustyrnaTM molecule, a ligand targeting COVID-19-SARS-COV-2 SPIKE D614G binding sites
researchopenworld.com
